AI imaging firm Brainomix is highlighting a series of new studies that were presented at the European Stroke Organization Conference (ESOC) in Basel, Switzerland.
The studies validated the impact of the Oxford-based company's Brainomix 360 Stroke platform, including its Triage Stroke tool and its e-Aspects software.
The studies follow an ESOC presentation of a prospective evaluation of stroke AI imaging that involved more than 80,000 patients at 26 sites over a three-year period. The study showed that the implementation of Brainomix 360 Stroke was tied to an additional 50% increase in the number of patients receiving mechanical thrombectomy and a reduction in door-in/door-out time of around 50 minutes.
